+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID06313801

Randomized Study Comparing First-line Polychemotherapy Alone Versus Polychemotherapy Combined With PIPAC Sessions for Gastric Cancer With Peritoneal Carcinomatosis

Led by Nizhny Novgorod Regional Clinical Oncology Center · Updated on 2025-11-21

106

Participants Needed

1

Research Sites

61 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying treatment options for patients with gastric cancer that has spread to the peritoneum, known as peritoneal carcinomatosis. This randomized phase 2 trial compares the safety and effectiveness of standard polychemotherapy using the FLOT regimen with a combination of polychemotherapy and pressurized intraperitoneal aerosol chemotherapy PIPAC sessions. The goal is to evaluate whether adding PIPAC improves outcomes such as progression-free survival and complications from treatment. Participants are divided into two groups after initial diagnostic laparoscopy. The control group receives six courses of polychemotherapy using the FLOT scheme, with evaluations after the 3rd and 6th courses including repeat diagnostic laparoscopy. The study group receives six courses alternating between FLOT and modified FLOT mFLOT regimens, combined with PIPAC sessions using docetaxel during the 2nd, 4th, and 6th courses. Instead of repeat laparoscopy, this group has revisions during the PIPAC sessions. Treatment response is monitored by the Peritoneal Regression Grading Score PRGS. During the study, participants undergo regular examinations, biopsies, peritoneal lavage for cytology, and assessments of tumor spread. The study monitors progression-free survival over four and a half years and complications from chemotherapy over three and a half years. Secondary outcomes include overall survival, quality of life, surgical complications, and the completeness of planned therapy. Patients may be observed or considered for cytoreductive surgery based on their response, with second-line chemotherapy or palliative care options if needed. The total study duration allows for ongoing monitoring and follow-up.

CONDITIONS

Brief Title

Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

Research Team

S

Sergey Klimin

N

Nikolai Kiselev

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here